Literature DB >> 9165577

Primary signet ring cell carcinoma of the bladder: a report on 10 cases.

S Holmäng1, G Borghede, S L Johansson.   

Abstract

Primary signet ring cell cancer of the urinary bladder is a rare tumour with some 70 cases reported to date. We report on ten additional cases with long-term follow-up. All 713 primary bladder tumours in western Sweden diagnosed during a 2-year period were prospectively registered and followed and all the histopathological material reviewed. A clinical and histopathological review of 816 bladder tumours from the files of the Oncology Clinic treated between 1962 and 1989 was performed. An incidence of primary signet ring cell carcinoma of 0.6% was found. Three out of five patients who were worked up as a result of an occasional episode of macroscopic haematuria were tumour-free 2, 5 and 14 years, respectively, after radical transurethral resection. Seven patients died of the disease after 5-26 (median 19) months. Our study and a review of the literature indicate that the majority of patients with primary signet ring cell carcinomas are diagnosed at an advanced stage and survival is poor. However, some patients with small tumours at diagnosis were tumour-free after transurethral resection. Radiotherapy was ineffective in most cases. Systemic chemotherapy is of no benefit.

Entities:  

Mesh:

Year:  1997        PMID: 9165577     DOI: 10.3109/00365599709070320

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  10 in total

1.  Metastatic signet-ring cell carcinoma of the urinary bladder: A novel management approach to a rare tumour.

Authors:  Neil Pugashetti; Stanley A Yap; Primo N Lara; Regina Gandour-Edwards; Marc A Dall'Era
Journal:  Can Urol Assoc J       Date:  2015 Mar-Apr       Impact factor: 1.862

2.  Metastatic signet-ring cell cancer of the bladder responding to chemotherapy with capecitabine: case report and review of literature.

Authors:  Jorg Michels; Sean Barbour; Douglas Cavers; Kim N Chi
Journal:  Can Urol Assoc J       Date:  2010-04       Impact factor: 1.862

3.  The impact of signet-ring cell carcinoma histology on bladder cancer outcome.

Authors:  Jue Wang; Fen Wei Wang; Anne Kessinger
Journal:  World J Urol       Date:  2011-06-25       Impact factor: 4.226

4.  Metastatic signet ring cell adenocarcinoma of the bladder: responsive to treatment?

Authors:  Jessica Singh; Viktor Zherebitskiy; David Grynspan; Piotr Marek Czaykowski
Journal:  Can Urol Assoc J       Date:  2012-02       Impact factor: 1.862

5.  Increased frequency and nocturia in a middle aged male may not always be due to benign prostatic hypertrophy: a case report.

Authors:  Kumar Gaurav; Jamie Fitch; Mukta Panda
Journal:  Cases J       Date:  2009-09-15

6.  Increased frequency and nocturia in a middle aged male may not always be due to Benign Prostatic Hypertrophy (BPH): a case report.

Authors:  Kumar Gaurav; Jamie Fitch; Mukta Panda
Journal:  Cases J       Date:  2009-10-27

7.  Primary urachal mucinous adenocarcinoma of the urinary bladder.

Authors:  Iqbal Singh; Ravi Prasad
Journal:  J Clin Diagn Res       Date:  2013-05-01

8.  Case Report: Metastatic Signet-Ring-Cell Carcinoma of the Bladder From Breast Invasive Lobular Carcinoma Detected by Computed Tomography.

Authors:  Xiaoxiang Jin; Haibin Tang; Hualin Chen; Gang Chen
Journal:  Front Oncol       Date:  2022-02-16       Impact factor: 6.244

9.  Surgery improves survival in bladder signet-ring cell carcinoma-a population-based study.

Authors:  Mohammed Alradhi; Mohammed Safi; Shenghua Tao; Abdullah Al-Danakh; Marwan Almoiliqy; Salem Baldi; Xiancheng Li
Journal:  Ther Adv Urol       Date:  2022-04-07

10.  Clinicopathological Characteristics and Prognostic Factors of Primary Bladder Signet Ring Cell Carcinoma.

Authors:  Liang Liu; Qiang Wang; Haibo Yuan
Journal:  J Healthc Eng       Date:  2022-09-05       Impact factor: 3.822

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.